Global Tuberculosis Drug Market Insights and Forecast to 2026

Global Tuberculosis Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Tuberculosis Drug Product Introduction
1.2 Market Segments
1.3 Key Tuberculosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Drug Market Size Growth Rate by Type
1.4.2 First-line Anti-TB Drugs
1.4.3 Second-line Anti-TB Drugs
1.5 Market by Application
1.5.1 Global Tuberculosis Drug Market Size Growth Rate by Application
1.5.2 Active TB
1.5.3 Latent TB
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Tuberculosis Drug Revenue 2015-2026
2.1.2 Global Tuberculosis Drug Sales 2015-2026
2.2 Global Tuberculosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tuberculosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tuberculosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tuberculosis Drug Competitor Landscape by Players
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Tuberculosis Drug Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tuberculosis Drug Revenue in 2019
3.2.5 Global Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Tuberculosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tuberculosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Drug Market Size by Type (2015-2020)
4.1.1 Global Tuberculosis Drug Sales by Type (2015-2020)
4.1.2 Global Tuberculosis Drug Revenue by Type (2015-2020)
4.1.3 Tuberculosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tuberculosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Tuberculosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Tuberculosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Tuberculosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tuberculosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Drug Market Size by Application (2015-2020)
5.1.1 Global Tuberculosis Drug Sales by Application (2015-2020)
5.1.2 Global Tuberculosis Drug Revenue by Application (2015-2020)
5.1.3 Tuberculosis Drug Price by Application (2015-2020)
5.2 Tuberculosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Tuberculosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Tuberculosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Tuberculosis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Drug by Country
6.1.1 North America Tuberculosis Drug Sales by Country
6.1.2 North America Tuberculosis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tuberculosis Drug Market Facts & Figures by Type
6.3 North America Tuberculosis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Tuberculosis Drug by Country
7.1.1 Europe Tuberculosis Drug Sales by Country
7.1.2 Europe Tuberculosis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Drug Market Facts & Figures by Type
7.3 Europe Tuberculosis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tuberculosis Drug by Region
8.1.1 Asia Pacific Tuberculosis Drug Sales by Region
8.1.2 Asia Pacific Tuberculosis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tuberculosis Drug Market Facts & Figures by Type
8.3 Asia Pacific Tuberculosis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tuberculosis Drug by Country
9.1.1 Latin America Tuberculosis Drug Sales by Country
9.1.2 Latin America Tuberculosis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tuberculosis Drug Market Facts & Figures by Type
9.3 Central & South America Tuberculosis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Drug by Country
10.1.1 Middle East and Africa Tuberculosis Drug Sales by Country
10.1.2 Middle East and Africa Tuberculosis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tuberculosis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Tuberculosis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Lupin
11.1.1 Lupin Corporation Information
11.1.2 Lupin Description and Business Overview
11.1.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Tuberculosis Drug Products Offered
11.1.5 Lupin Related Developments
11.2 Otsuka Novel Products
11.2.1 Otsuka Novel Products Corporation Information
11.2.2 Otsuka Novel Products Description and Business Overview
11.2.3 Otsuka Novel Products Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Otsuka Novel Products Tuberculosis Drug Products Offered
11.2.5 Otsuka Novel Products Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Tuberculosis Drug Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Tuberculosis Drug Products Offered
11.4.5 Sanofi Related Developments
11.1 Lupin
11.1.1 Lupin Corporation Information
11.1.2 Lupin Description and Business Overview
11.1.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lupin Tuberculosis Drug Products Offered
11.1.5 Lupin Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tuberculosis Drug Market Estimates and Projections by Region
12.1.1 Global Tuberculosis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Tuberculosis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Tuberculosis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Tuberculosis Drug Sales Forecast (2021-2026)
12.2.2 North America: Tuberculosis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Tuberculosis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Tuberculosis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Tuberculosis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tuberculosis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tuberculosis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tuberculosis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tuberculosis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Tuberculosis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Tuberculosis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Tuberculosis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tuberculosis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tuberculosis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tuberculosis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tuberculosis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Tuberculosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tuberculosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Tuberculosis Drug Market Segments
Table 2. Ranking of Global Top Tuberculosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tuberculosis Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of First-line Anti-TB Drugs
Table 5. Major Manufacturers of Second-line Anti-TB Drugs
Table 6. Global Tuberculosis Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Tuberculosis Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Tuberculosis Drug Sales by Regions 2015-2020 (K MT)
Table 9. Global Tuberculosis Drug Sales Market Share by Regions (2015-2020)
Table 10. Global Tuberculosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Tuberculosis Drug Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Tuberculosis Drug Sales Share by Manufacturers (2015-2020)
Table 13. Global Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Tuberculosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Drug as of 2019)
Table 15. Tuberculosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Tuberculosis Drug Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Tuberculosis Drug Price (2015-2020) (USD/MT)
Table 18. Tuberculosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Tuberculosis Drug Product Type
Table 20. Date of International Manufacturers Enter into Tuberculosis Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 23. Global Tuberculosis Drug Sales Share by Type (2015-2020)
Table 24. Global Tuberculosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Tuberculosis Drug Revenue Share by Type (2015-2020)
Table 26. Tuberculosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 28. Global Tuberculosis Drug Sales Share by Application (2015-2020)
Table 29. North America Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 30. North America Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 31. North America Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 33. North America Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 34. North America Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 35. North America Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 36. North America Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 37. Europe Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 38. Europe Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 39. Europe Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 41. Europe Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 42. Europe Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 43. Europe Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 44. Europe Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Tuberculosis Drug Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Tuberculosis Drug Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Tuberculosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Tuberculosis Drug Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 53. Latin America Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 54. Latin America Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 57. Latin America Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 58. Latin America Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 59. Latin America Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 60. Latin America Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Tuberculosis Drug Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Tuberculosis Drug Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Tuberculosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Tuberculosis Drug Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Tuberculosis Drug Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Tuberculosis Drug Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Tuberculosis Drug Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Tuberculosis Drug Sales Market Share by Application (2015-2020)
Table 69. Lupin Corporation Information
Table 70. Lupin Description and Major Businesses
Table 71. Lupin Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Lupin Product
Table 73. Lupin Recent Development
Table 74. Otsuka Novel Products Corporation Information
Table 75. Otsuka Novel Products Description and Major Businesses
Table 76. Otsuka Novel Products Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Otsuka Novel Products Product
Table 78. Otsuka Novel Products Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Tuberculosis Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Global Tuberculosis Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 90. Global Tuberculosis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Tuberculosis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Tuberculosis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 94. North America: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 96. Europe: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Tuberculosis Drug Sales Forecast by Region (2021-2026) (K MT)
Table 98. Asia Pacific: Tuberculosis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 100. Latin America: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Tuberculosis Drug Sales Forecast by Country (2021-2026) (K MT)
Table 102. Middle East and Africa: Tuberculosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Tuberculosis Drug Players
Table 107. Tuberculosis Drug Customers List
Table 108. Tuberculosis Drug Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Drug Product Picture
Figure 2. Global Tuberculosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. First-line Anti-TB Drugs Product Picture
Figure 4. Second-line Anti-TB Drugs Product Picture
Figure 5. Global Tuberculosis Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Active TB
Figure 7. Latent TB
Figure 8. Tuberculosis Drug Report Years Considered
Figure 9. Global Tuberculosis Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Tuberculosis Drug Sales 2015-2026 (K MT)
Figure 11. Global Tuberculosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Tuberculosis Drug Sales Market Share by Region (2015-2020)
Figure 13. Global Tuberculosis Drug Sales Market Share by Region in 2019
Figure 14. Global Tuberculosis Drug Revenue Market Share by Region (2015-2020)
Figure 15. Global Tuberculosis Drug Revenue Market Share by Region in 2019
Figure 16. Global Tuberculosis Drug Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis Drug Revenue in 2019
Figure 18. Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Tuberculosis Drug Sales Market Share by Type (2015-2020)
Figure 20. Global Tuberculosis Drug Sales Market Share by Type in 2019
Figure 21. Global Tuberculosis Drug Revenue Market Share by Type (2015-2020)
Figure 22. Global Tuberculosis Drug Revenue Market Share by Type in 2019
Figure 23. Global Tuberculosis Drug Market Share by Price Range (2015-2020)
Figure 24. Global Tuberculosis Drug Sales Market Share by Application (2015-2020)
Figure 25. Global Tuberculosis Drug Sales Market Share by Application in 2019
Figure 26. Global Tuberculosis Drug Revenue Market Share by Application (2015-2020)
Figure 27. Global Tuberculosis Drug Revenue Market Share by Application in 2019
Figure 28. North America Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Tuberculosis Drug Sales Market Share by Country in 2019
Figure 31. North America Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 32. U.S. Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Tuberculosis Drug Market Share by Type in 2019
Figure 37. North America Tuberculosis Drug Market Share by Application in 2019
Figure 38. Europe Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Tuberculosis Drug Sales Market Share by Country in 2019
Figure 41. Europe Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 42. Germany Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Tuberculosis Drug Market Share by Type in 2019
Figure 53. Europe Tuberculosis Drug Market Share by Application in 2019
Figure 54. Asia Pacific Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Tuberculosis Drug Sales Market Share by Region in 2019
Figure 57. Asia Pacific Tuberculosis Drug Revenue Market Share by Region in 2019
Figure 58. China Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Tuberculosis Drug Market Share by Type in 2019
Figure 81. Asia Pacific Tuberculosis Drug Market Share by Application in 2019
Figure 82. Latin America Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Tuberculosis Drug Sales Market Share by Country in 2019
Figure 85. Latin America Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 86. Mexico Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Tuberculosis Drug Market Share by Type in 2019
Figure 93. Latin America Tuberculosis Drug Market Share by Application in 2019
Figure 94. Middle East and Africa Tuberculosis Drug Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Tuberculosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Tuberculosis Drug Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Tuberculosis Drug Revenue Market Share by Country in 2019
Figure 98. Turkey Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Tuberculosis Drug Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Tuberculosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Tuberculosis Drug Market Share by Type in 2019
Figure 105. Middle East and Africa Tuberculosis Drug Market Share by Application in 2019
Figure 106. North America Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Tuberculosis Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Tuberculosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Tuberculin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Tuberculin market size was valued at US$ 270 million in 2023. With growing demand in downstream market, the Tuberculin is forecast to a readjusted size of US$ 384.7 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Tuberculin market. Tuberculin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......

Global Tuberculin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 98

According to our (Global Info Research) latest study, the global Tuberculin market size was valued at USD 284 million in 2023 and is forecast to a readjusted size of USD 393.9 million by 2030 with a CAGR of 4.8% during review period. Tuberculin, also known as purified protein derivative is a combination of proteins that are used in the diagnosis of tuberculosis. This use is referred to as the tuberculin skin test and is recommended only for those at high risk. Injection is done into the ......

Pyrazinamide - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110

The global Pyrazinamide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pyrazinamide in various end use industries. The expanding demands from the Children and Adult, are propelling Pyrazinamide market. Purity 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity 99% segment is estima......

Ethambutol - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 105

The global Ethambutol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ethambutol in various end use industries. The expanding demands from the Chemical Industry and Pharmaceutical Industry, are propelling Ethambutol market. Reagent Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Medi......

Global Pyrazinamide Professional Survey Report 2023, Forecast to 2028

Published: 14-Dec-2023        Price: US 3280 Onwards        Pages: 130

Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. ......

Global Pyrazinamide Market Research Report 2023, Forecast to 2028

Published: 14-Dec-2023        Price: US 2680 Onwards        Pages: 162

Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. ......

Global Ethambutol Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Ethambutol market: According to our latest research, the global Ethambutol market looks promising in the next 5 years. As of 2022, the global Ethambutol market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ethambutol market, with a systematical de......

Global Isoniazid Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Isoniazid market: According to our latest research, the global Isoniazid market looks promising in the next 5 years. As of 2022, the global Isoniazid market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Isoniazid market, with a systematical descri......

Global Isoniazid Market Research Report 2023

Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 90

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Isoniazid market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - AMSAL CHEM - Resonance Specialties - Calyx Pharma & Chem - Camus pharma - Titan Pharma (India) - Taizhou Tianrui Pharmaceutical - Zhejiang Second Pha......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs